Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_4
2
50%
Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Completed1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (66.7%)
N/A1 (33.3%)

Trials by Status

unknown125%
completed125%
recruiting125%
terminated125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

NCT05022459
unknownphase_4

Preventing Inhibitor Recurrence Indefinitely

NCT04621916
completedphase_4

Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients

NCT02727647
terminatednot_applicable

Individually Tailored Prophylaxis in Patients With Severe Hemophilia A

NCT00995046

Clinical Trials (4)

Showing 4 of 4 trials
NCT05022459

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

Recruiting
NCT04621916Phase 4

Preventing Inhibitor Recurrence Indefinitely

Unknown
NCT02727647Phase 4

Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients

Completed
NCT00995046Not Applicable

Individually Tailored Prophylaxis in Patients With Severe Hemophilia A

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4